Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rowena A Bull

Showing results (101-110 of 112) with videos related to

Pageof 12
Sort By:
Cell Reports. Medicine|March 22, 2021
Long-term persistence of RBD<sup>+</sup> memory B cells encoding neutralizing antibodies in SARS-CoV-2 infectionArunasingam Abayasingam, Harikrishnan Balachandran, David Agapiou, et al.
Nature Communications|February 8, 2023
Broadly neutralizing SARS-CoV-2 antibodies through epitope-based selection from convalescent patientsRomain Rouet, Jake Y Henry, Matt D Johansen, et al.
Cell Reports. Medicine|March 5, 2023
A systems immunology study comparing innate and adaptive immune responses in adults to COVID-19 mRNA and adenovirus vectored vaccinesFeargal J Ryan, Todd S Norton, Conor McCafferty, et al.
Nature Communications|February 28, 2018
Clonally diverse CD38<sup>+</sup>HLA-DR<sup>+</sup>CD8<sup>+</sup> T cells persist during fatal H7N9 diseaseZhongfang Wang, Lingyan Zhu, Thi H O Nguyen, et al.
Cell Reports|January 29, 2022
Maintenance of broad neutralizing antibodies and memory B cells 1 year post-infection is predicted by SARS-CoV-2-specific CD4+ T cell responsesHarikrishnan Balachandran, Chansavath Phetsouphanh, David Agapiou, et al.
Viruses|June 11, 2020
Tenth Scientific Biennial Meeting of the Australasian Virology Society-AVS10 2019Karla J Helbig, Rowena A Bull, Rebecca Ambrose, et al.
Cell Reports. Medicine|June 2, 2022
SARS-CoV-2 Omicron variant escapes neutralizing antibodies and T cell responses more efficiently than other variants in mild COVID-19 convalescentsPablo Garcia-Valtanen, Christopher M Hope, Makutiro G Masavuli, et al.
Immunity|November 17, 2021
Immunizations with diverse sarbecovirus receptor-binding domains elicit SARS-CoV-2 neutralizing antibodies against a conserved site of vulnerabilityDeborah L Burnett, Katherine J L Jackson, David B Langley, et al.
Journal of Virology|April 25, 2025
Twelfth scientific biennial meeting of the Australasian Virology Society: AVS12 2024Ebony A Monson, Robson K Loterio, Justin A Roby, et al.
Journal of Virology|April 25, 2023
Statement in Support of: "Virology under the Microscope-a Call for Rational Discourse"Peter Speck, Jason Mackenzie, Rowena A Bull, et al.
Pageof 12

Showing results (101-110 of 112) with videos related to

Sort By:
Pageof 12
Cell Reports. Medicine|March 22, 2021
Long-term persistence of RBD<sup>+</sup> memory B cells encoding neutralizing antibodies in SARS-CoV-2 infectionArunasingam Abayasingam, Harikrishnan Balachandran, David Agapiou, et al.
Nature Communications|February 8, 2023
Broadly neutralizing SARS-CoV-2 antibodies through epitope-based selection from convalescent patientsRomain Rouet, Jake Y Henry, Matt D Johansen, et al.
Cell Reports. Medicine|March 5, 2023
A systems immunology study comparing innate and adaptive immune responses in adults to COVID-19 mRNA and adenovirus vectored vaccinesFeargal J Ryan, Todd S Norton, Conor McCafferty, et al.
Nature Communications|February 28, 2018
Clonally diverse CD38<sup>+</sup>HLA-DR<sup>+</sup>CD8<sup>+</sup> T cells persist during fatal H7N9 diseaseZhongfang Wang, Lingyan Zhu, Thi H O Nguyen, et al.
Cell Reports|January 29, 2022
Maintenance of broad neutralizing antibodies and memory B cells 1 year post-infection is predicted by SARS-CoV-2-specific CD4+ T cell responsesHarikrishnan Balachandran, Chansavath Phetsouphanh, David Agapiou, et al.
Viruses|June 11, 2020
Tenth Scientific Biennial Meeting of the Australasian Virology Society-AVS10 2019Karla J Helbig, Rowena A Bull, Rebecca Ambrose, et al.
Cell Reports. Medicine|June 2, 2022
SARS-CoV-2 Omicron variant escapes neutralizing antibodies and T cell responses more efficiently than other variants in mild COVID-19 convalescentsPablo Garcia-Valtanen, Christopher M Hope, Makutiro G Masavuli, et al.
Immunity|November 17, 2021
Immunizations with diverse sarbecovirus receptor-binding domains elicit SARS-CoV-2 neutralizing antibodies against a conserved site of vulnerabilityDeborah L Burnett, Katherine J L Jackson, David B Langley, et al.
Journal of Virology|April 25, 2025
Twelfth scientific biennial meeting of the Australasian Virology Society: AVS12 2024Ebony A Monson, Robson K Loterio, Justin A Roby, et al.
Journal of Virology|April 25, 2023
Statement in Support of: "Virology under the Microscope-a Call for Rational Discourse"Peter Speck, Jason Mackenzie, Rowena A Bull, et al.
Pageof 12